Skip to Main Content

Paper Details

A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
npj Precision Oncology
85
2018
CRC, HER2+, HER2+ breast cancer, KRAS, KRAS-, KRAS- and BRAF-mutant tumors, MAPK, MEK, MPAS, adrenal cancer, breast cancer, cancer, cancer cell lines, cancers, cell, cell lines, cobimetinib, melanomas, oncogenes, tumor, vemurafenib

Datasets

Release 1.2